LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapies Luminopia is pioneering innovative digital therapeutics for neuro-visual disorders, presenting an opportunity for tailored solutions in the biotechnology market.

Funding Success With recent funding of $16M in Series A, Luminopia has the financial backing to scale operations and potentially expand its product offerings, signaling partnership opportunities.

Strategic Partnerships Luminopia's collaboration with Boston Children's Hospital and key investors like U.S. Venture Partners and ShangBay Capital opens doors for strategic partnerships in the healthcare industry.

Top Talent Acquisition The addition of industry expert Casey Tansey to Luminopia's Board of Directors indicates a focus on attracting top talent, hinting at collaboration opportunities with influential figures.

Market Validation Luminopia's FDA-approved treatments and successful fundraising rounds demonstrate market demand and investor confidence, offering a potential edge in competitive positioning.

Similar companies to Luminopia

Luminopia Tech Stack

Luminopia uses 8 technology products and services including Unpkg, Google Hosted Libraries, jsDelivr, and more. Explore Luminopia's tech stack below.

  • Unpkg
    Content Delivery Network
  • Google Hosted Libraries
    Content Delivery Network
  • jsDelivr
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Webflow
    Page Builders

Luminopia's Email Address Formats

Luminopia uses at least 1 format(s):
Luminopia Email FormatsExamplePercentage
First@luminopia.comJohn@luminopia.com
43%
Last@luminopia.comDoe@luminopia.com
7%
First@luminopia.comJohn@luminopia.com
43%
Last@luminopia.comDoe@luminopia.com
7%

Frequently Asked Questions

Where is Luminopia's headquarters located?

Minus sign iconPlus sign icon
Luminopia's main headquarters is located at 625 Massachusetts Ave Cambridge, Massachusetts 02139 US. The company has employees across 2 continents, including North AmericaEurope.

What is Luminopia's phone number?

Minus sign iconPlus sign icon
You can contact Luminopia's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Luminopia's official website and social media links?

Minus sign iconPlus sign icon
Luminopia's official website is luminopia.com and has social profiles on LinkedIn.

What is Luminopia's SIC code NAICS code?

Minus sign iconPlus sign icon
Luminopia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Luminopia have currently?

Minus sign iconPlus sign icon
As of August 2024, Luminopia has approximately 33 employees across 2 continents, including North AmericaEurope. Key team members include Chief Business Officer: B. R.Head Of Market Access: S. R.Co-Founder & Chairman: D. T.. Explore Luminopia's employee directory with LeadIQ.

What industry does Luminopia belong to?

Minus sign iconPlus sign icon
Luminopia operates in the Biotechnology Research industry.

What technology does Luminopia use?

Minus sign iconPlus sign icon
Luminopia's tech stack includes UnpkgGoogle Hosted LibrariesjsDelivrFont AwesomeReactjQueryOpen GraphWebflow.

What is Luminopia's email format?

Minus sign iconPlus sign icon
Luminopia's email format typically follows the pattern of . Find more Luminopia email formats with LeadIQ.

How much funding has Luminopia raised to date?

Minus sign iconPlus sign icon
As of August 2024, Luminopia has raised $16M in funding. The last funding round occurred on Jun 27, 2023 for $16M.

When was Luminopia founded?

Minus sign iconPlus sign icon
Luminopia was founded in 2016.
Luminopia

Luminopia

Biotechnology ResearchMassachusetts, United States11-50 Employees

Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. 

Please see Luminopia Directions For Use for more information: luminopia.com/dfu

Section iconCompany Overview

Headquarters
625 Massachusetts Ave Cambridge, Massachusetts 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $16M

    Luminopia has raised a total of $16M of funding over 5 rounds. Their latest funding round was raised on Jun 27, 2023 in the amount of $16M.

Section iconFunding & Financials

  • $16M

    Luminopia has raised a total of $16M of funding over 5 rounds. Their latest funding round was raised on Jun 27, 2023 in the amount of $16M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.